# FDA Inspection 1055694 - Biomat USA, Inc - June 05, 2018

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/6c33270e-9242-42af-bd2f-a7c2420f4969
Source feed: FDA_Inspections

> FDA Inspection 1055694 for Biomat USA, Inc on June 05, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1055694
- Company Name: Biomat USA, Inc
- Inspection Date: 2018-06-05
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 948683 - 2015-11-05](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/6f07f66c-0f37-4003-a7b7-fd1866528d39)
- [FDA Inspection 846389 - 2013-08-30](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/37420652-1c94-4f07-bce3-f40163dc568f)
- [FDA Inspection 724744 - 2011-05-16](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/53833afe-0336-485f-b9d0-0070a2395a9c)
- [FDA Inspection 561267 - 2009-02-09](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/10b4a7b9-72f6-4fd0-9e70-f3735cfdd803)

Company: https://www.keypedia.com/companies/biomat-usa-inc/fe77aeaf-8724-43c8-930a-0650ca6a9e53

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d